Minirin Melt (Desmopressin)

Desmopressin, the active ingredient in Minirin Melt, is a vasopressin analog presented as a sublingual melt tablet for sublingual use. It treats central diabetes insipidus, nocturnal enuresis, hemophilia A and von Willebrand disease in appropriate patients.

GNH USA supplies Minirin Melt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to reduce urine output and promote hemostasis.

- Central diabetes insipidus: reduces excessive thirst and urine volume by enhancing water reabsorption in the kidneys. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Hemophilia A: raises plasma factor VIII levels to improve clot formation. - Von Willebrand disease: increases von Willebrand factor release, aiding platelet adhesion.

Desmopressin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Nasal congestion: feeling of a blocked nose. - Nausea: upset stomach or urge to vomit. - Mild hyponatremia: low sodium levels, often asymptomatic.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to seizures or coma. - Water intoxication: excessive fluid retention causing edema. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Thrombotic events: rare clot formation.

Before prescribing Minirin Melt, clinicians should consider several safety measures.

- Renal function: assess kidney function prior to initiation. - Electrolytes: monitor serum sodium regularly, especially in high‑risk patients. - Fluid intake: advise patients to limit excessive water consumption. - Concomitant drugs: avoid use with other antidiuretic agents. - Cardiovascular disease: use caution in patients with heart failure or hypertension. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Desmopressin can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - NSAIDs: may potentiate antidiuretic effect and increase hyponatremia risk. - Carbamazepine: enhances desmopressin‑induced water retention. - Tricyclic antidepressants: increase risk of severe hyponatremia.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): can exacerbate electrolyte disturbances. - Anticoagulants (e.g., warfarin): may alter bleeding risk when desmopressin is used for hemostasis. - Oral contraceptives: may increase water retention.